Rodman & Renshaw has recently initiated CorMedix Inc (CRMD) stock to Buy rating, as announced on August 26, 2024, according to Finviz. Earlier, on August 10, 2023, RBC Capital Mkts had initiated the ...
RBC Capital analyst Brad Heffern lowered the firm’s price target on Agree Realty (ADC) to $79 from $80 and keeps an Outperform rating on the shares after its 2025 investment volume update. RBC notes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback